UMN removes interim VP after Regents rebuke M Physicians–Fairview funding deal
The University of Minnesota Board of Regents unanimously passed a Nov. 13 resolution criticizing M Physicians for negotiating a roughly $1 billion funding deal with Fairview, saying the group overstepped its authority, directing it to negotiate with the University and warning the pact could affect how Minnesota trains doctors. Days later UMN removed Dr. Greg Beilman from his interim vice president for clinical operations role — he remains interim CEO of M Physicians and a faculty surgeon — saying the move addressed concerns about dual roles and protected the integrity of negotiations, while Fairview and M Physicians say they have a binding term sheet aimed at a definitive agreement by the end of 2025 and that AG Keith Ellison urged direct talks.
📌 Key Facts
- In mid‑November (Nov. 13–14), the University of Minnesota Board of Regents unanimously passed a resolution criticizing M Physicians for negotiating a roughly $1 billion funding agreement with Fairview.
- The Regents’ formal resolution escalated the dispute, called M Physicians' actions “unlawful,” directed M Physicians to negotiate with the University, and warned the pact could affect how Minnesota trains its doctors.
- UMN ended Dr. Greg Beilman’s interim appointment as vice president for clinical operations on Nov. 19.
- Beilman remains interim CEO of M Physicians and retains his UMN faculty chair and surgical roles.
- UMN said removing Beilman followed the mid‑November Regents resolution and was intended to address concerns about dual‑role leaders and to protect the integrity of ongoing negotiations involving M Physicians, Fairview and the University.
- Fairview and M Physicians said they executed a binding agreement with a detailed term sheet and aim to reach a definitive agreement by the end of 2025; the current University–Fairview deal expires in 2026.
- M Physicians reported that Minnesota Attorney General Keith Ellison pushed for direct negotiations with Fairview in September.
📰 Sources (3)
- UMN ended Dr. Greg Beilman’s interim appointment as vice president for clinical operations on Nov. 19.
- Beilman remains interim CEO of M Physicians and keeps his UMN faculty chair and surgical roles.
- UMN said the move follows the Nov. 13 Board of Regents resolution addressing concerns about dual-role leaders and protecting the integrity of ongoing negotiations with M Physicians and Fairview.
- The Regents’ resolution asserted M Physicians acted “unlawfully,” overstepping its authority, and directed M Physicians to negotiate with the University.
- Fairview and M Physicians said last week they executed a binding agreement with a detailed term sheet and aim for a definitive agreement by end of 2025; the current U–Fairview deal expires in 2026.
- M Physicians noted AG Keith Ellison pushed for direct negotiations with Fairview in September.
- UMN Board of Regents unanimously passed a resolution criticizing the physician group for negotiating a $1 billion funding agreement with Fairview.
- The resolution escalates the dispute over the pact and signals potential implications for how Minnesota trains its doctors.
- This is a formal board action beyond prior administrative opposition letters.